Ultra-modern medicine: the paradoxes of innovation

Of numerous publications have highlighted the interactions between health and innovation; and demonstrated that there is no technological reform without health gains or health gains without inventing new concepts. By ultra-modern medicine, we can first of all understand the need for a technically augmented medicine recognized as both efficient and ethical.

A medicine rather based on communication hygiene

Today, the proliferation of social networks and digital means of communication has led to a proliferation of false information, excessive popularization and intox. The e-patient no longer needs to communicate, to share his knowledge, his experiences, his information, seeking to disentangle the true from the false. Of course, innovation has contributed to the evolution of the patient’s place in the care pathway. Some patients living with a chronic disease thus become patient-experts…

The “medical paternalism” which made the patient a simple executor of the act of care tends to be transformed into a participative contract, especially nowadays, when diseases that were once fatal are becoming more and more chronic. This is also the case in the face of the increase in what are called multimodal diseases -involving several organs or several regions of the human body at the same time-, requiring a boost in communication between patients and caregivers, in order to “simplify” the diagnosis and, in turn, the prognosis.

Omics: an additional weapon in the arsenal of the clinician of tomorrow

In medical practice, “omics” technologies make it possible to understand complex and dynamic biological systems as a whole. The best known “omics” are genomics (identification of genetic variants for example), epigenomics (DNA methylation for example), transcriptomics (analysis of gene expression), proteomics ( protein analysis) or even metabolomics (analysis of the metabolites produced).

These new techniques make it possible to study the associations between different “omics” markers and a pathology, an environmental factor, an exposure, the response to a treatment, etc. Coupled with data sciences, “omics” technologies make it possible to generate new knowledge on the physiopathological mechanisms of diseases and to identify new biomarkers associated with these pathologies, which represent so many new potential therapeutic targets. Studies have shown that medication side effects are the seventh leading cause of hospitalization in Canada and the fourth leading cause of death in the United States. Better targeted drugs could perhaps reduce the number of hospitalizations and, consequently, reduce health-related costs. They also enable the development and application of new technologies for disease prevention (biosensors, diagnostic tools, new treatments, etc.).

An ultra-modern medicine is a medicine that is more attentive to the problems of aging, its long-term objective “immortality” and in the short and medium term, a cellular slowdown, in other words, the transition of a system that treats diseases related to aging to a system that considers aging as a pathology as such. A medicine that is more attentive to the smallest detail of our brain, to the circadian relationships determining the passage between the state of wakefulness and sleep. A medicine that is constantly developing neuroscientific aspects to repair, replace and even improve our sick and even healthy brains. Ultramodern medicine is a wave of innovation that seeks to create artificial intelligence (AI) producing machines “interfaced” with the human brain to make it hybrid, capable of using an infinite mass of data available on a “cloud / cloud”.

Ultra-modern medicine is a first step towards transhumanist thinking and augmented man.